10.2 Recordkeeping, Storage & Handling

Recordkeeping, Storage & Handling

Beyond controlled substances, every prescription a New York pharmacy fills — legend drugs, prescription-only devices, compounds — creates records governed by 8 NYCRR §63.6, NYSED's core pharmacy practice regulation. This section covers what must be kept, how long, and how the physical pharmacy must be built and secured to hold it all safely.

Prescription and Patient Record Retention

New York sets a five-year retention floor across the major categories of pharmacy records under §63.6:

• Prescription hard copies / electronic prescriptions — retained at the pharmacy for five years from the date of the most recent filling (§63.6(a)(7)(ii)(c)). A prescription refilled several times keeps resetting its own five-year clock from the latest fill, not the original write date.
• Facsimile-transmitted prescriptions — the same five-year period applies.
• Transferred prescriptions — when a prescription is transferred to or from another pharmacy, the transfer documentation is retained for five years from the date of filling (§63.6(a)(8)(iv)).
• Patient medication profiles — maintained in a retrievable form for five years following the date of the most recent entry (§63.6(b)(7)). The profile must capture patient demographics, known allergies and drug reactions, chronic disease states, and medication history — the clinical backbone the pharmacist relies on for drug utilization review (DUR) and counseling.

This is meaningfully longer than the two-year federal minimum for ordinary drug purchase invoices under 21 CFR 1304.04 — a contrast the MPJE likes to test, because candidates who default to "two years, like the DEA rule" for every New York record will get prescription- and profile-retention questions wrong.

Electronic Records and Shared Databases

Electronic prescriptions must be "electronically encrypted" — protected against access, alteration, or use by any unauthorized person (§63.6(a)(7)(ii)(b)). Many New York pharmacies participate in common electronic files or databases shared across multiple pharmacies (chain-wide systems, DUR networks) that hold personally identifiable dispensing information. Under §63.6, a pharmacy accessing such a shared database may pull a patient's information from it only upon the express request of the patient or a person authorized to act on the patient's behalf — a pharmacist cannot browse another pharmacy's fill history on a shared system simply because the system happens to be technically accessible.

Physical Storage, Security & Handling

Section 63.6(b) also sets physical construction and security minimums for the pharmacy premises itself:

• Minimum pharmacy size — not less than 300 square feet.
• Compounding/dispensing area — not less than 100 square feet within that space.
• Refrigeration — temperature-controlled storage maintained between 2°C and 8°C (36°F–46°F) for drugs requiring cold storage.
• Radioactive drugs — a separate, secured storage and dispensing area, inaccessible to unauthorized personnel (§63.6(b)(6)(iii)); records of radioactive drug receipt/disposition carry the same five-year retention as other drug records.
• General standards — proper sanitary appliances, and the pharmacy kept clean and orderly, with minimum equipment (weighing devices, measuring devices, mortar and pestle) on hand to compound and dispense safely.

Equipment and Compounding Standards

The minimum-equipment list in §63.6(b) is not a suggestion — it is what a BNE or NYSED inspector checks against on a routine or complaint-driven site visit. A pharmacy must have on hand a functioning weighing device accurate enough for the smallest quantities it compounds, a measuring device appropriate to liquid preparations, and a mortar and pestle (or equivalent) for solid and semisolid compounding. Storage areas must be kept in a condition that protects drug integrity: clean, orderly, free of pest activity, and separated so that non-drug stock (cleaning supplies, retail merchandise in a combination store) cannot contaminate or be mistaken for pharmaceutical inventory. Inspectors treat a missing or non-functional required item the same way they treat a missing record — as a recordkeeping/operations deficiency, because the equipment exists specifically to make the compounding and dispensing records that §63.6 requires trustworthy.

These physical and equipment standards work together with the record-retention rules above: a patient medication profile is only as reliable as the counseling and DUR process that feeds it, and that process depends on the pharmacist having accurate weighing and measuring tools, secure refrigerated storage for temperature-sensitive drugs, and a radioactive-drug area that keeps low-frequency but high-risk inventory properly isolated. On the MPJE, a fact pattern that combines a storage deficiency (for example, a broken refrigerator holding insulin at improper temperature) with a documentation question (how long the incident must be documented and retained) is testing whether you can connect the physical-standards rule to the recordkeeping rule rather than treating them as two unrelated topics.

Records & Retention Summary Table

Exam Traps

• "How long must a New York pharmacy keep a five-times-refilled prescription on file?" — Five years from the most recent fill, not the original date written.
• "Can a pharmacist look up a patient's fill history on a shared chain database without being asked?" — No; access to a shared electronic file is limited to instances where the patient (or an authorized representative) has expressly requested it.
• "What is the minimum size of a New York pharmacy?" — 300 square feet overall, with at least 100 square feet set aside for compounding and dispensing.
• "Is New York's prescription retention period the same as the DEA's two-year invoice minimum?" — No; New York requires five years for prescriptions and patient profiles under §63.6, well beyond the federal two-year floor for ordinary purchase invoices.